Sun's U.S. Unit Recalls 200 Vials Of Chemotherapy Drug For Sterility Issue
This article was originally published in PharmAsia News
Executive Summary
The U.S. FDA said Caraco Pharmaceutical Laboratories, the U.S. unit of Sun Pharmaceutical Industries, has recalled 200 vials of its injectable gemcitabine because of a sterility problem at Caraco's plant in Gujarat, India.